Authors


Tricia Chaney

Latest:

Pursuing a Calling: From Convent to Cancer Care

How Kathleen Shannon Dorcy, PhD, RN, FAAN, became a leading voice in oncology nursing.


Sarah Paul, LCSW, OSW-C

Latest:

Embracing Vicarious Resilience in Oncology Nursing: A Light in the Dark

The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.


Jennifer Wenzel, PhD, RN, CCM, FAAN

Latest:

Jennifer Wenzel on Prioritizing Representation in Clinical Trials

Jennifer Wenzel, PhD, RN, CCM, FAAN, discusses why representation in clinical trials is not successful as an afterthought.


Maria Cabanillas

Latest:

Know Your Thyroid Cancer Before Deciding on Treatment

Maria Cabanillas, MD, explains that for people who are newly diagnosed with thyroid cancer, it is imperative that they know all the details about their cancer before heading into surgery. 


Pamela Malloy, MN, FPCN

Latest:

Preparing Oncology Nurses to Provide Palliative Care to Patients and Families

Research has demonstrated that integrating palliative care early for patients with advanced cancer improves outcomes such as quality of life, mood, patient satisfaction, prognostic understanding, health service use, and survival.


Carol Cannon, RN, BSN, OCN

Latest:

Carol Cannon Discusses the ONS Get Up, Get Moving Campaign

Carol Cannon, RN, BSN, OCN, Oncology Program Specialist, Nurse Oncology Education Program, Austin, Texas, discusses the ONS Get Up, Get Moving Campaign.


Erin Wallace

Latest:

Study Finds Regional Disparities in Access to Specialist Gynecologic Cancer Care

Women living in certain areas of the United States may face health risks due to their limited access to specialized gynecologic cancer care.


Emily Mason Beard, BSN, RN, OCN, CBCN

Latest:

Talking With Young Patients With Breast Cancer About Ovarian Suppression Treatment

Balancing quality-of-life concerns with treatment goals is complicated for young patients with hormone-sensitive breast cancers.


Saundra Buys, MD

Latest:

Helping Patients Overcome Fear of Genetic Testing to Uncover Cancer Risks

In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.


Victoria Puzo, LCSW, MSW

Latest:

What Are the Needs of Cancer Survivors 5 Years or More After Treatment?

For patients with cancer, their journey does not end after treatment is over.


Deirdre Kiely, MS, MPA, RN, ANP

Latest:

Deirdre Kiely Discusses the Challenges of Getting Breast Cancer Patients to Exercise

Deirdre Kiely, MS, MPA, RN, ANP, nurse practitioner, Perlmutter Cancer Center at NYU Langone Medical Center, discusses some of the challenges of getting breast cancer patients to exercise routinely.


Michael Wang, MD

Latest:

CAR T-Cell Therapy Can Help Overcome Resistance to Treatment

When patients with MCL develop resistance to chemotherapy and targeted therapies, experts believe CAR T-cell therapy can step in.


Debu Tripathy, MD

Latest:

Debu Tripathy on Hormone Therapy Compliance in Patients with Breast Cancer

Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.


Carol Tringali, MS, RN

Latest:

Carol Tringali on Closing the Gaps in Psychosocial Care

Carol Tringali on Closing the Gaps in Psychosocial Care


Bobbie J. Rimel, MD

Latest:

Understanding the Adverse Events of PARP Inhibitors

There are some adverse events that are common to all PARP inhibitors, and others that are specific to each drug.


Melanie A. Nix

Latest:

Melanie A. Nix on the Importance of Social Media in Advocacy

Melanie A. Nix, co-founder of the Breast Cancer Comfort Site, comments on the importance of social media in advocacy.


Mary McCabe

Latest:

Mary McCabe on the Evolution of Survivorship Care

Mary McCabe, director, Cancer Survivorship Initiative, Memorial Sloan Kettering Cancer Center, discusses the evolution of survivorship care.


Kerryn Reding, PhD, MPH, RN

Latest:

With New Breast Cancer Treatments Come Lasting Toxicity

About a third of breast cancer survivors are still living with fatigue and reduced exercise capacity after treatment ends.


Jennifer Brown RN, BSN, CPN, CPHON

Latest:

Obesity and Childhood Cancer

Survivors of childhood cancer who are overweight or obese as adults are at an increased risk of developing an obesity-related cancer.


Robert Andtbacka, MD

Latest:

Robert Andtbacka Discusses T-VEC Trials

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.



Mark E. Robson, MD

Latest:

Mark E. Robson Discusses When Genetic Testing Is Needed

​Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.


Kathleen M. Madden, MSN, FNP-BC, AOCNP

Latest:

Kathleen Madden on Managing AEs From Targeted Therapies for Melanoma

Kathleen M. Madden discusses the management of adverse events (AEs) with BRAF and MEK inhibitors for the treatment of patients with melanoma.


Gregory T. Armstrong, MD, MSCE

Latest:

Dr. Gregory T. Armstrong on Improved Outcomes for Childhood Cancer Survivors

Gregory T. Armstrong, MD, MSCE, pediatric oncologist, St. Jude Children's Research Hospital, discusses a trial of 34,000 childhood cancer survivors.


Lois Rajcan, MSN, RN, CRNI

Latest:

Nurse Trust Among Patients With Ports

Research has shown that pain and anxiety are related to port access, so a need exists to capture patients’ feelings and emotions related to living with a port, as well as effective nursing interventions aimed at addressing those patient experiences.


Colleen Jennings, RN, BSN, HN-BC

Latest:

Colleen Jennings on Improving Follow-Up Phone Calls

Colleen Jennings, RN, BSN, HN-BC, discusses how to improve follow-up phone calls.


Colleen Moretti

Latest:

Sacituzumab Govitecan Significantly Prolongs Overall Survival in Patients With HR+/HER2- Metastatic Breast Cancer

Sacituzumab govitecan may represent a promising option for patients with endocrine resistant, hormone receptor–positive/HER2-negative metastatic breast cancer, according to updated findings from the phase 3 TROPiCs-02 study.


John Kirkwood, MD

Latest:

John Kirkwood on Training Physicians on Skin Examinations

John Kirkwood, MD, Usher professor, Medicine, Dermatology and Translational Science, co-director, Melanoma and Skin Cancer Program, University of Pittsburgh, discusses training physicians on skin examinations for detecting melanoma. 


Laura Galindez, MSW

Latest:

Spotlight on Integrative Oncology Navigation

Using integrative modalities such as behavior therapies, mindfulness meditation and creative arts therapy can support a patient with cancer during treatment.


© 2024 MJH Life Sciences

All rights reserved.